4

Back to all posts

Press Release
AlphaLogix announces market release of AlphaFlo® canine allograft
AlphaFlo-Press-Release-Image

Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.

You may want to read these articles

RenoVō® CASE STUDY: Bilateral Corneal Ulcers

RenoVō® CASE STUDY: Bilateral Corneal Ulcers

August 11, 2020: A horse presented to The Equine Performance Center, Ocala, FL, with bilateral corneal ulcers. Following eye examination, sub-palpebral lavage was placed in both eyes and IV catheter was placed. The horse received aggressive medical therapy including...

RenoVō® CASE STUDY: KERATITIS

RenoVō® CASE STUDY: KERATITIS

Case presentation: June 13, 2022: A 12 year-old Gelding Trakehner Dressage Horse presented to Topgun Veterinarian Service, Rock Hill, SC, with a history of generalized keratitis in the right eye. Medical history included corneal...

RenoVō® CASE STUDY: HOOF INJURY

RenoVō® CASE STUDY: HOOF INJURY

Patient: Jake Case presentation: On November 20, 2019, a Quarter Horse gelding got entangled in a barbed wire fence and lacerated his right, rear hoof as he was pulling back from the fence. Radiograph examination of the foot revealed barbed wire pieces lodged inside...